109 A WHOLE-BRAIN CLASSIFIER APPROACH FOR REAL-TIME FMRI FEEDBACK TRAINING IN COCAINE ADDICTION. A R Childress 1,2 , J Magland 1 , Z Wang 1 , A V Hole 1,2 , J J Suh 1,2 , A Fornash 1,2 , D Willard 1 , R Fabianski 1 , R Cars<strong>on</strong> 1 , R Hazan 1 , R N Ehrman 1,2 , T R Franklin 1 , M Goldman 1 , R Szucs Reed 1 , C P O’Brien 1,2 ; 1 Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA, 2 VA VISN 4 MIRECC, Philadelphia, PA Aims: Regi<strong>on</strong>-specific real-time fMRI feedback has enabled subjects to c<strong>on</strong>trol pain-modulating brain activity, and to achieve pain relief. <str<strong>on</strong>g>The</str<strong>on</strong>g>se pi<strong>on</strong>eering studies encourage similar rtfMRI feedback attempts for “craving circuit modulati<strong>on</strong>” in addicti<strong>on</strong>, but the relevant brain regi<strong>on</strong>s are not yet fully characterized, may be spatially distributed, and may vary across individuals. We are thus testing whether a “whole brain” classifier approach may be used 1) to rapidly distinguish the brain states associated with viewing cocaine vs. n<strong>on</strong>-drug videos, and 2)to provide rtfMRI feedback for c<strong>on</strong>trolling the brain state associated with viewing a cocaine video. Methods: BOLD fMRI at 3T with a partial least squares (PLS)linear classifier was used to characterize the whole brain resp<strong>on</strong>se to alternating 30 sec cocaine vs. n<strong>on</strong>-drug videos in cocaine patients (n=5; <strong>on</strong>going) and c<strong>on</strong>trols (n=2; <strong>on</strong>going). Real-time visual feedback based <strong>on</strong> this classifier was provided to two c<strong>on</strong>trols via a cursor adjacent to the <strong>on</strong>going video, with instructi<strong>on</strong>s to attempt c<strong>on</strong>trol of the cursor by increasing or decreasing the state associated with viewing the target video. Results: <str<strong>on</strong>g>The</str<strong>on</strong>g> whole-brain classifier based <strong>on</strong> PLS regressi<strong>on</strong> robustly distinguished (15
113 AN ELECTRONIC HEALTH SYSTEM IN OPIOID AGONIST TREATMENT CLINICS: STUDY DESIGN AND BASELINE CHARACTERISTICS. M Chu, Steven A Kritz, R Zavala, L S Brown; Medical Services, Research and Informati<strong>on</strong> Technology, ARTC, Brooklyn, NY Aims: Electr<strong>on</strong>ic health systems (EHS) are comm<strong>on</strong>ly included in healthcare reform discussi<strong>on</strong>s; however, their impact in addicti<strong>on</strong> treatment has not been examined. We report pre and post implementati<strong>on</strong> quality, productivity, patient and staff satisfacti<strong>on</strong>, and financial performance results of an integrated EHS in an outpatient opioid ag<strong>on</strong>ist treatment program c<strong>on</strong>sisting of 7 clinics providing primary medical and HIV care for approximately 3000 predominantly minority adults in New York City. Methods: Specific aims were selected using a pre-study needs assessment of stakeholders. Quality measures included viral load assessment in hepatitis C virus (HCV) infected patients and timely assessment of medical and addicti<strong>on</strong> status at various intervals. <str<strong>on</strong>g>The</str<strong>on</strong>g> number of counseling, primary care, and HIV case management visits represented productivity measures. Using an an<strong>on</strong>ymous survey, patient and staff satisfacti<strong>on</strong> were assessed. Financial performance was measured as revenue per capita staff and cost per patient visit. Results: Pre-implementati<strong>on</strong> results were as follows: (1) Quality: HCV viral load was appropriately performed in 92% of cases; annual medical assessments were timely for 83% of cases; annual addicti<strong>on</strong> assessments were timely at 30 days, 90 days, and annually for 81%, 46%, and 70% of cases, respectively. (2) Productivity: <str<strong>on</strong>g>The</str<strong>on</strong>g>re were 64345 counseling visits, 5221 primary medical care visits, and 2680 HIV case management visits. (3) Satisfacti<strong>on</strong>: Seventy-four percent of patients were satisfied/very satisfied with their care, while 33% of clinicians and managers were satisfied/very satisfied with the pre-EHS system for providing care. (4) Financial performance: Revenue per capita staff was $66,900 and cost per patient visit was $31.34. Post-implementati<strong>on</strong> data is being compiled. C<strong>on</strong>clusi<strong>on</strong>s: <str<strong>on</strong>g>The</str<strong>on</strong>g>se results provide insight into the state of primary care and addicti<strong>on</strong> treatment delivery in <strong>on</strong>e large program and a basis for assessing the impact of an integrated EHS, further informing healthcare reform discussi<strong>on</strong>s. Financial Support: Nati<strong>on</strong>al Institute <strong>on</strong> Drug Abuse: R01 DA022030 115 RISK OF DEATH AND CRIME AMONG PROGRAM- QUITTERS. Thomas Clausen 1 , S Skurtveit 2,1 ; 1 Norwegian Centre for Addicti<strong>on</strong> Research, University of Oslo, Oslo, Norway, 2 Department of Pharmacoepidemiology, Norwegian Institute of Public Health, Oslo, Norway Aims: Mortality rates typically increase am<strong>on</strong>g opioid maintenance treatment (OMT) terminators. <str<strong>on</strong>g>The</str<strong>on</strong>g> observed increase in death-risk may be due to the “absence of treatment”, or it may be explained by selecti<strong>on</strong> effects. This study investigates crime (criminal charge) rates prior to treatment as a predictor for death after treatment terminati<strong>on</strong>, in order to highlight possible selecti<strong>on</strong> mechanisms. Methods: Criminal charges are c<strong>on</strong>sidered as a proxy variable for “risk behaviour”. Data <strong>on</strong> all opiate dependents in Norway (1997-2003) who applied for and/or were accepted for OMT (n=3789) were cross linked with the Norwegian death registry. In additi<strong>on</strong> registry-data <strong>on</strong> recorded criminal charges from the Nati<strong>on</strong>al Crime registry for the three years prior to first applicati<strong>on</strong> date (n=>20.000 charges) for treatment was included. Data were analysed according to pre-treatment crime levels and post-treatment group comparis<strong>on</strong>s between survivors (n=711) and deceased (n=46). Results: Pre-treatment crime levels varied significantly between treatment terminator survivors and deceased. Mean number of criminal charges during the 3 years prior to treatment applicati<strong>on</strong>, were 10 and 16 for survivors and deceased, respectively. Both groups had higher rates of pre-treatment criminal charges compared to treatment compliers with mean; 6 and 7 criminal charges for survivors and deceased, respectively. C<strong>on</strong>clusi<strong>on</strong>s: Already prior to OMT applicati<strong>on</strong> those who later terminate treatment and particularly those who die post-treatment differ in terms of higher levels of criminal behaviour than those who comply with treatment. <str<strong>on</strong>g>The</str<strong>on</strong>g> observati<strong>on</strong> of high death risk post-treatment seems to be partly caused by selecti<strong>on</strong> mechanisms, not <strong>on</strong>ly the “absence of treatment”. <str<strong>on</strong>g>The</str<strong>on</strong>g> findings imply that prior to treatment high criminal activity is a detectable predictive factor associated with treatment adherence and outcome. This opens an opportunity for earlier interventi<strong>on</strong>s in order to avoid treatment terminati<strong>on</strong> and ultimately post-treatment death. Financial Support: <str<strong>on</strong>g>The</str<strong>on</strong>g> study has received a 3-year PhD-grant from the Research Council of Norway. <str<strong>on</strong>g>CPDD</str<strong>on</strong>g> <str<strong>on</strong>g>72nd</str<strong>on</strong>g> <str<strong>on</strong>g>Annual</str<strong>on</strong>g> <str<strong>on</strong>g>Meeting</str<strong>on</strong>g> <str<strong>on</strong>g>•</str<strong>on</strong>g> <str<strong>on</strong>g>Scottsdale</str<strong>on</strong>g>, <str<strong>on</strong>g>Ariz<strong>on</strong>a</str<strong>on</strong>g> 29 114 ASSOCIATION BETWEEN CINGULATE VOLUME AND IMPULSIVITY IN ADOLESCENT CANNABIS SMOKERS. John C Churchwell, E Bueler, D A Yurgelun-Todd; School of Medicine, University of Utah, <str<strong>on</strong>g>The</str<strong>on</strong>g> Brain Institute, Salt Lake City, UT Aims: Cannabis is the most frequently selected drug of choice for initiates 12 years and older in the U.S and is thought to have a neurocognitve impact related to early use. Increased impulsivity during adolescence may be related to substance use initiati<strong>on</strong>. Further, functi<strong>on</strong>al neuroimaging studies have shown altered activati<strong>on</strong> of the cingulate cortex, a regi<strong>on</strong> known to mediate impulsive behavior and cogniti<strong>on</strong>, in cannabis abusing adults. <str<strong>on</strong>g>The</str<strong>on</strong>g>refore, we hypothesized that adolescent cannabis abusers (CA) would differ from healthy c<strong>on</strong>trols (HC) in both impulsivity and cingulate volume. Methods: Thirty-six subjects from the Salt Lake City area completed diagnostic interviews and drug screens. Structural imaging data was acquired <strong>on</strong> eighteen CA subjects (17.7 ± 0.9 years) and eighteen HC subjects (17.2 ± 0.8 years) using a T1-weighted 3D MPRAGE sequence <strong>on</strong> a 3T Siemens Trio magnet. Volumetric segmentati<strong>on</strong> was performed with Freesurfer and adjusted volumes were obtained by taking the ratio of segmented cingulate volumes to total segmented brain volume. <str<strong>on</strong>g>The</str<strong>on</strong>g> Barratt Impulsivity Scale (BIS) was used to assess impulsivity. Results: CA subjects had significantly higher scores <strong>on</strong> the BIS planning subscale (p= .01), a measure of decreased future orientati<strong>on</strong>, when compared to c<strong>on</strong>trols. Compared to HC, the CA group also showed a str<strong>on</strong>g trend (p= 0.06) toward increased volume for the right rostral anterior cingulate regi<strong>on</strong>. Moreover, for the CA group, total right cingulate volume was correlated with both total BIS score (r= .52, p= .02) and with the BIS planning subscale (r= .74, p= .001). C<strong>on</strong>clusi<strong>on</strong>s: <str<strong>on</strong>g>The</str<strong>on</strong>g>se findings suggest a relati<strong>on</strong>ship between levels of self-reported impulsivity, future orientati<strong>on</strong>, and cingulate volume in adolescent cannabis abusers. Protracted development of prefr<strong>on</strong>tal cortical systems during adolescence is thought to c<strong>on</strong>tribute to delayed behavioral maturati<strong>on</strong> and increased impulsivity. <str<strong>on</strong>g>The</str<strong>on</strong>g>se findings suggest that morphometry of the cingulate may play a role in the <strong>on</strong>set of drug use. Financial Support: Research supported by funding from NIH grant DA020269 116 PRESCRIPTION OPIOID ABUSE PREDICTS FIRST ADMISSION INTO METHADONE MAINTENANCE TREATMENT. Charles Cleland 1 , A Rosenblum 1 , C F<strong>on</strong>g 1 , M Parrino 2 , S Magura 3 ; 1 NDRI, New York, NY, 2 American Associati<strong>on</strong> for the Treatment of Opioid Dependence, New York, NY, 3 Western Michigan University, Kalamazoo, MI Aims: To determine which prescripti<strong>on</strong> opioids (POs) (as well as other factors) c<strong>on</strong>tribute to first admissi<strong>on</strong> into methad<strong>on</strong>e maintenance treatment (MMT) Methods: A nati<strong>on</strong>al survey was c<strong>on</strong>ducted am<strong>on</strong>g 22,846 patients enrolling in 85 MMT programs between Jan. 2005 and Sept. 2009. (Regi<strong>on</strong>s where PO abuse was believed to be prevalent were oversampled.) A logistic regressi<strong>on</strong> model for predicting first MMT episode was c<strong>on</strong>structed. Interview date, age, gender, race, regi<strong>on</strong>, chr<strong>on</strong>ic pain, craving, withdrawal severity, and urbanicity were included as covariates. Past m<strong>on</strong>th heroin use and 10 POs (buprenorphine, hydrocod<strong>on</strong>e, morphine, hydromorph<strong>on</strong>e, fentanyl, extended release oxycod<strong>on</strong>e, immediate release oxycod<strong>on</strong>e, methad<strong>on</strong>e liquid, methad<strong>on</strong>e disks, and methad<strong>on</strong>e pills) also were included as potential predictors. (Separate methad<strong>on</strong>e formulati<strong>on</strong>s were included because disks and liquid are typically dispensed at MMT programs and pills are typically prescribed to pain patients and dispensed at pharmacies.) Adjusted odds ratios (AOR) for effects p < .01 are reported. Results: Mean age was 34, 79% were white, 40% female, 60% living in counties with > 1M residents, 41% chr<strong>on</strong>ic pain, 56% used heroin and 72% used <strong>on</strong>e or more POs. First admissi<strong>on</strong> MMT enrollees (50%) were more likely to be using hydrocod<strong>on</strong>e (AOR=1.48), extended release oxycod<strong>on</strong>e (AOR=1.42) and immediate release oxycod<strong>on</strong>e (AOR=1.29) and less likely to be using heroin (AOR=0.56), methad<strong>on</strong>e liquid (AOR=0.38), and hydromorph<strong>on</strong>e (AOR=0.83). New enrollees were also more likely to be younger, living in n<strong>on</strong>urban areas, male, white, have chr<strong>on</strong>ic pain, have higher drug craving, and a more recent enrollment date. C<strong>on</strong>clusi<strong>on</strong>s: First MMT episode is associated with several, but not all types, of POs. Characteristics correlated with first MMT episode suggest a different demographic than has traditi<strong>on</strong>ally been associated with MMT enrollment. Financial Support: Funded by Rocky Mountain Pois<strong>on</strong> and Drug Center as part of the Researched Abuse Diversi<strong>on</strong> and Addicti<strong>on</strong>-Related Surveillance (RADARS®) System.